STOCKS TELEGRAPH

Tag: Aeterna Zentaris

  • Want to Know Why Aeterna Zentaris Inc. (AEZS) Stock is on a Rally, Here’s Your Answer

    Aeterna Zentaris Inc. (AEZS), a specialty biopharmaceutical company, has gained a monumental increase of 5.65% in aftermarket trading session. As a result, AEZS stock is trading at $0.52 at the time of the writing. On Thursday, AEZS closed the day at $0.49 after increasing 4.66% during regular trading hours. The increase has come despite no apparent news or press release which could have prompted that. So for the moment, let’s discuss its recent developments.

    AEZS Q3 2021 Operational Results

    On 4th November, AEZS released the operational results for the third quarter of the fiscal year 2021. The quarter ended on 30th September 2021. The company generated total revenue of $0.6 million during the quarter against $0.1 million for the same period of 2020. The total operating expenses bore by the company during the quarter were $2.4 million against $1.9 million for the same quarter of 2020. The net finance income generated by the company during the period was $0.1 million against $0.6 million for the same period of 2020. The consolidated net loss suffered by the company during the period was $1.7 million (or $0.01 per common share) against $0.01 per common share) against $11 million (or $0.02 per common share) for the same period of 2020.

    AEZS: Business Highlights

    Alongside the operational results, AEZS also reported recent business highlights. The company had entered into an exclusive license with Julius-Maximilians-University of Wuerzburg. The license was about the early pre-clinical development of AIM Biologics which could prove handy in the treatment of Parkinson’s disease. The company also exercised its option to expand the application of the oral vaccine platform to chlamydia under the agreement.

    Executive Commentary

    Dr. Klaus Paulini, Chief Executive Officer of AEZS, while commenting on the results said that since the start of the year, the company had concerted efforts not only to advance its clinical-stage program but also to expand its development pipeline. He said that the company is diligently working to execute the advancements of all its clinical and pre-clinical programs and is poised to continue building value in the long term.

    Future Outlook for AEZS

    During the last three months, AEZS stock has declined more than 30%. However, recent performances depict that the stock is a hot and popular entity among investors. So, potential investors should keep a close eye on the developments related to AEZS stock to reap the upcoming benefits.

  • Aeterna Zentaris Inc. (AEZS) Releases 2020 Financial Earnings

    Aeterna Zentaris Inc. (AEZS) is a biopharmaceutical company that specializes in manufacturing and distributing therapeutics and tests used for medical diagnosis. The company is also expanding its current development pipeline and clinical trials of macimorelin- which will be used in the diagnosis of a growth hormone deficiency, an area without adequate medical need.

    The company Regained agreement with minimum bid price policy for continued listing on Nasdaq and AEZS common shares had a close bought deal for gross capital exceeding $34 million. The company also received $20M in capital from share dilution and using warrants.

    AEZS Plans For Pipeline Expansion

    AEZS continued to execute its pipeline expansion developing its pre-clinical programs via several licensing agreements with European universities. The Company started an official license agreement with Julius-Maximilians-University of Wuerzburg, Germany, having international patent and rights to produce and advertise, extremely distinct immunosuppressive protein therapeutics expecting treatment for Neuromyelitis Optica spectrum disorder, which has an unmet medical need.

    The company also amended its current license with Novo Nordisk for manufacturing Macrilen to penetrate Canadian and American markets.  AEZS is currently meeting the concerned medical authorities for confirmation of preclinical data required to advance into human clinical trials.

    Production of a Potential Oral Bacterial Vaccine For COVID-19

    AEZS has announced to be part of an exclusive international sub-licensable contract for a COVID 19 vaccine which is present in an initial development phase at the Julius-Maximilians-University. The company has a research agreement and is already looking for a pre-clinical trial for the potential vaccine.

    The vaccine uses the salmonella strain as an orally active live-attenuated bacteria to prevent COVID 19 improving the immune response against mutated viruses.

    Conclusion

    AEZS is in the lucrative field of biopharmaceuticals and is keen on research for vaccines of COVID and diseases with unmet medical needs. Savvy financial moves like share dilution and close bought deals have given the company a market capitalization of a staggering $135M and is anticipating a surge in revenue if the covid 19 vaccines produce efficient results.

  • 41 Stocks Making Sharp Moves in Pre Market Session

    41 Stocks Making Sharp Moves in Pre Market Session

    NanoVibronix Inc. (NASDAQ: NAOV) shares are trading down -4.55% at $1.05 at the time of writing after announcing $6.0 million private placement. Company’s 52-week ranged between $0.54 to $3.50.
    Merrimack Pharmaceuticals Inc. (MACK) stock plunged -6.93% to $6.04 in the pre-market trading. The most recent rating by JP Morgan, on October 07, 2016, is a Neutral.
    Curis Inc. (CRIS) is down more than -5.85% at $1.77 in pre-market hours Thursday December 03, 2020 after declaring that it will host Virtual Event to discuss CA-4948 clinical data. The stock had jumped over 22.88% to $1.88 in the last trading session.
    Before the trading started on December 03, 2020, Obalon Therapeutics Inc. (OBLN) is down -8.62% to reach $1.06. It has been trading in a 52-week range of $0.62 to $2.14.
    Artelo Biosciences Inc. (ARTL) grew over 7.53% at $0.7065 in pre-market trading today following announcement its appointment of drug discovery and development veteran Gregory R. Reyes, M.D., Ph.D. to the Company’s Board of Directors.
    Acorda Therapeutics Inc. (ACOR), a Biotechnology company, dropped about -3.54% at $0.79 in pre-market trading Thursday.
    Ampio Pharmaceuticals Inc. (AMPE) is up more than 6.8% at $1.1 in pre-market hours Thursday December 03, 2020 after declaring its phase I study for Inhaled Ampion advances to completing enrollment of COVID-19 patients with respiratory distress. The stock had jumped over 12.65% to $1.03 in the last trading session.
    Nxt-ID Inc. (NASDAQ: NXTD) shares are trading down -6.11% at $0.446 at the time of writing. Company’s 52-week ranged between $0.21 to $0.89.
    OrganiGram Holdings Inc. (OGI) stock moved down -2.86 percent to $1.36 in the pre-market trading. The company recently released fourth quarter 2020 results.
    InVivo Therapeutics Holdings Corp. (NVIV) gained over 14.27% at $0.7999 in pre-market trading Thursday December 03, 2020.
    HEXO Corp. (HEXO) lost over -5.98% at $1.1 in pre-market trading Thursday December 03, 2020 as the firm recently revealed that it has repositioned the UP Cannabis brand with a differentiator of 20% THC or higher in all dried flower products, every time.
    Before the trading started on December 03, 2020, Aurora Cannabis Inc. (ACB) is down -2.92% to reach $10.63. It has been trading in a 52-week range of $3.71 to $32.88.
    Before the trading started on December 03, 2020, Golar LNG Limited (GLNG) is down -6.67% to reach $8.75 after declaring that it intends to offer, issue and sell to the public 11,000,000 common shares, par value $1.00 per share, through an underwritten public offering. It has been trading in a 52-week range of $4.54 to $15.24.
    Aeterna Zentaris Inc. (AEZS) stock soared 3.1% to $0.455 in the pre-market trading. The most recent rating by Maxim Group, on July 19, 2017, is a Buy.
    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) shares are trading up 9.23% at $4.26 at the time of writing after reporting that it has screened the first patients in a global trial of its oral insulin capsule ORMD-0801 for the treatment of Nonalcoholic steatohepatitis (NASH). Company’s 52-week ranged between $2.40 to $6.05. Analysts have a consensus price target of $5.50.
    Ashford Hospitality Trust Inc. (AHT), a REIT – Hotel & Motel company, rose about 7.36% at $2.48 in pre-market trading Thursday.
    Ideanomics Inc. (IDEX) grew over 0.86% at $2.35 in pre-market trading today. The technology firm lately declared that its subsidiary, Tree Technologies Sd. Bhd., which owns the Treeletrik brand, has hired Richard Teoh as its Chief Financial Officer.
    AIkido Pharma Inc. (AIKI) is down more than -2.2% at $0.59 in pre-market hours Thursday December 03, 2020. The stock had jumped over 8.94% to $0.60 in the last trading session.
    NIO Limited (NIO), a Auto Manufacturers company, dropped about -2.21% at $46.92 in pre-market trading Thursday after providing its November 2020 delivery results.
    Genius Brands International Inc. (GNUS) is up more than 2.14% at $1.43 in pre-market hours Thursday December 03, 2020. The stock had jumped over 5.26% to $1.40 in the last trading session.
    Micro Focus International plc (MFGP) gained over 2.81% at $5.12 in pre-market trading Thursday December 03, 2020 following the publication its findings of ‘Endless Modernization’ research with Standish Group.
    Trine Acquisition Corp. (NYSE: TRNE) shares are trading up 6.44% at $14.22 at the time of writing. Company’s 52-week ranged between $9.40 to $13.94.
    Before the trading started on December 03, 2020, Borr Drilling Limited (BORR) is down -6.29% to reach $0.7625. The firm recently declared unaudited results for the three and nine months ended September 30, 2020. It has been trading in a 52-week range of $0.24 to $9.12.
    Blink Charging Co. (BLNK), a Specialty Retail company, dropped about -2.83% at $22.35 in pre-market trading Thursday.
    Boxlight Corporation (BOXL) lost over -2.53% at $1.54 in pre-market trading Thursday December 03, 2020. An education technology firm recently reported that Shaun Marklew has been appointed as Chief Technology Officer and Patrick Foley will be appointed as Chief Financial Officer on January 16, 2021.
    Before the trading started on December 03, 2020, Pyxis Tankers Inc. (PXS) is up 10.87% to reach $1.02. It has been trading in a 52-week range of $0.62 to $1.37.
    Orbital Energy Group Inc. (OEG) is down more than -3.1% at $1.25 in pre-market hours Thursday December 03, 2020 following announcement its wholly-owned transmission & distribution division, Orbital Power Services signed a Master Services Agreement with a midwestern investor-owned utility.
    Telefonica S.A. (TEF) is down more than -2.64% at $4.43 in pre-market hours Thursday December 03, 2020. The stock had jumped over 1.56% to $4.55 in the last trading session.
    Longview Acquisition Corp. (NYSE: LGVW) shares are trading up 7.86% at $15.79 at the time of writing. Company’s 52-week ranged between $9.34 to $17.99.
    UP Fintech Holding Limited (NASDAQ: TIGR) shares are trading up 3.51% at $5.61 at the time of writing. Company’s 52-week ranged between $2.03 to $7.60.
    Veru Inc. (VERU) gained over 10.39% at $3.4 in pre-market trading Thursday December 03, 2020.
    Tonix Pharmaceuticals Holding Corp. (TNXP) grew over 2.46% at $0.6414 in pre-market trading today.
    Before the trading started on December 03, 2020, Orange S.A. (ORAN) is down -5.39% to reach $12.28 after reporting that it plans to launch a conditional voluntary public takeover bid on all the shares of Orange Belgium that it does not yet own. It has been trading in a 52-week range of $9.93 to $16.08.
    Switchback Energy Acquisition Corporation (SBE) gained over 2.27% at $30.17 in pre-market trading Thursday December 03, 2020.
    Nano Dimension Ltd. (NNDM), a Computer Hardware company, rose about 4.69% at $6.7 in pre-market trading Thursday after closing the previously reported registered direct offering of 11,960,160 of the Company’s American Depositary Shares at a price of $5.00 per ADS.
    Harmony Gold Mining Company Limited (HMY) is down more than -2.42% at $4.44 in pre-market hours Thursday December 03, 2020. The stock had dropped over 0.00% to $4.55 in the last trading session.
    Waddell & Reed Financial Inc. (WDR) stock moved up 46.33 percent to $24.89 in the pre-market trading after declaring a merger agreement with Macquarie Asset Management, under which Macquarie would acquire Waddell & Reed Financial, Inc. for $1.7 Billion.
    Limelight Networks Inc. (LLNW) stock plunged -2.78% to $4.2 in the pre-market trading. The most recent rating by Goldman, on November 30, 2020, is a Neutral.
    Before the trading started on December 03, 2020, XP Inc. (XP) is down -1.88% to reach $39.65 after announcing pricing of public follow-on offering. It has been trading in a 52-week range of $15.50 to $52.94.
    CBAK Energy Technology Inc. (NASDAQ: CBAT) shares are trading up 2.75% at $7.1 at the time of writing. Company’s 52-week ranged between $0.36 to $11.40.
    Splunk Inc. (SPLK) tumbled over -20.5% at $163.69 in pre-market trading today as the firm released fiscal third quarter 2021 financial results.